Coupling features of intestinal and serum indole pools in obesity
- 作者: Shestopalov A.V1, Shatova O.P1, Zabolotneva A.A1, Gaponov A.M2, Moskaleva N.E3, Appolonova S.A3, Makarov V.V4, Yudin S.M4, Rumyantsev A.G5,1, Roumiantsev S.A1
-
隶属关系:
- Pirogov Russian National Research Medical University
- Dmitry Rogachev National Medical Research Centerof Pediatric, Hematology, Oncology and Immunology
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Center for Strategic Planning and Management of Biomedical Health Risks
- Dmitry Rogachev National Medical Research Center of Pediatric, Hematology, Oncology and Immunology
- 期: 卷 24, 编号 10 (2021)
- 页面: 3-12
- 栏目: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112886
- DOI: https://doi.org/10.29296/25877313-2021-10-01
- ID: 112886
如何引用文章
详细
全文:
作者简介
A. Shestopalov
Pirogov Russian National Research Medical University
Email: al-shest@yandex.ru
Dr.Sc. (Med.), Professor Moscow, Russia
O. Shatova
Pirogov Russian National Research Medical University
Email: shatova.op@gmail.com
Ph.D. (Med.), Associate Professor Moscow, Russia
A. Zabolotneva
Pirogov Russian National Research Medical University
Email: a.zabolotneva@gmail.com
Ph.D. (Biol.), Associate Professor Moscow, Russia
A. Gaponov
Dmitry Rogachev National Medical Research Centerof Pediatric, Hematology, Oncology and Immunology
Email: zorba@yandex.ru
Moscow, Russia
N. Moskaleva
I.M. Sechenov First Moscow State Medical University (Sechenov University)Ph.D. (Biol.), Senior Research Scientist Moscow, Russia
S. Appolonova
I.M. Sechenov First Moscow State Medical University (Sechenov University)Ph.D. (Chem.) Moscow, Russia
V. Makarov
Center for Strategic Planning and Management of Biomedical Health RisksPh.D. (Biol.), Analyst Moscow, Russia
S. Yudin
Center for Strategic Planning and Management of Biomedical Health RisksDr.Sc. (Med.), Professor, Director Moscow, Russia
A. Rumyantsev
Dmitry Rogachev National Medical Research Center of Pediatric, Hematology, Oncology and Immunology; Pirogov Russian National Research Medical UniversityDr.Sc. (Med.), Professor, Academician RAS, President; Honorary Professor Moscow, Russia
S. Roumiantsev
Pirogov Russian National Research Medical UniversityDr.Sc. (Med.), Professor, Corresponding Member of RAS Moscow, Russia
参考
- Zhang J., Guo Z., Xue Z., et al. A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME. J. 2015; 9: 197990; doi: 10.1038/ismej.2015.11.
- Agus A., Planchais J., SokolН. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host. Microbe. 2018; 6: 716-24; doi: 10.1016/j.chom.2018.05.003.
- Osadchiy V., Labus J.S., Gupta A., et al. Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects. PLoS. One. 13; 8: e0201772; doi: 10.1371/journal.pone.0201772.
- Wang S.Z., Yu Y.J., Adeli K. Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis. Microorganisms. 2020; 8(4): 527; doi: 10.3390/microorganisms8040527.
- Zhao Z.H., Xin F.Z., Xue Y. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Exp. Mol. Med. 2019; 51(9): 1-14; doi: 10.1038/s12276-019-0304-5.
- Knudsen C., Neyrinck A.M., Lanthier N., et al. Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? Curr. Opin. Clin. Nutr. Metab Care 2019; 22(5): 393-400; doi: 10.1097/MC0.0000000000000584.
- Krishnan S., Ding Y., Saedi N., et al. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepa-tocytes and macrophages. Cell Rep. 2018; 23(4): 1099-1111.
- Wong C.B., Tanaka A., Kuhara T., et al. Potential effects of indole-3-lactic acid, a metabolite of human bifidobacteria, on NGF-induced neurite outgrowth in PC12 cells. Microorganisms. 2020; 8(3): 1099-1111; doi: 10.1016/j.celrep.2018.03.109.
- Koay Y.C., Wali J.A., Luk S., et al. Ingestion of resistant starch by mice markedly increases microbiome-derived metabolites. FASEB J. 2019; 33(7): 8033-42; doi: 10.1096/fj.201900177R.
- Zhang L.S., Davies S.S. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 2016; 8(1): 46; doi: 10.1186/s13073-016-0296-x.
- www.genome.gp - KEGG Pathway - Tryptophan metabolism.
- Shestopalov A.V., Shatova O.P., Gaponov A.M., et al. The study of tryptophan metabolite concentrations in blood serum and fecal extracts from obese children. Biomed. Khim.; 66(6): 494-501; doi: 10.18097/PBMC20206606494.
- Santos-Paulo S., Costello S., Forster S., et al. The gut microbiota as a therapeutic target for obesity: a scoping review. Nutr. Res. Rev. 2021; 8: 1-33; doi: 10.1017/S0954422421000160.
- Sitkin S.I., Tkachenko E.I., Vakhitov T.Y. Metabolic dysbiosis of the gut microbiota and its biomarkers. Eksp. Klin. Gastroenterol. 2016; 12(12): 6-29.
- Гапонов А.М., Волкова Н.И., Ганенко Л.А. Особенности микробиома толстой кишки у пациентов с ожирением при его различных фенотипат. Журнал микробиологии, эпидемиологии и иммунобиологии. 2021; 98(2): 144-155; doi: 10.36233/0372-9311-66
- Comai S., Bertazzo A., Brughera M. Tryptophanin health and disease. Adv. Clin. Chem. 2020; 95: 165-218; doi: 10.1016/bs.acc.2019.08.005.
- Wu S., Liu J., Liu C., et al. Quorum sensing for population level control of bacteria and potential therapeutic applications. Cell Mol. Life Sci. 020; 77(7): 1319-43; doi: 10.1007/s00018-019-03326-8.
- Dehhaghi M., Kazemi P.H., Shariat, et al. Microorganisms, tryptophan metabolism, and kynurenine pathway: a complex interconnected loop influencing human health status. Int. J. Tryptophan. Res. 2019; 12: 1178646919852996; doi: 10.1177/1178646919852996.